Tag: clinical trials

Documenting Transition/Exit Plans & Knowledge Transfer for Audits, Health Authority Queries and Due Diligence Documenting Transition/Exit Plans & Knowledge Transfer for Audits, Health Authority Queries and Due Diligence In the highly regulated landscape of clinical trials, documenting transition and exit plans, along with effective knowledge transfer, is essential for maintaining compliance and readiness for audits,…

Read More “Documenting Transition/Exit Plans & Knowledge Transfer for Audits, Health Authority Queries and Due Diligence” »

Digital Tools and Automation That Transform Transition/Exit Plans & Knowledge Transfer in Clinical Development Digital Tools and Automation That Transform Transition/Exit Plans & Knowledge Transfer in Clinical Development The landscape of clinical trials is undergoing a significant transformation with the integration of digital tools and automation. These technologies are crucial for effective transition and exit…

Read More “Digital Tools and Automation That Transform Transition/Exit Plans & Knowledge Transfer in Clinical Development” »

Case Studies: Transition/Exit Plans & Knowledge Transfer That Rescued High-Risk Studies and Vendors Case Studies: Transition/Exit Plans & Knowledge Transfer That Rescued High-Risk Studies and Vendors In the realm of clinical trials, effective management of transition and exit strategies is critical. The future of clinical trials is contingent upon the ability to minimize disruptions while…

Read More “Case Studies: Transition/Exit Plans & Knowledge Transfer That Rescued High-Risk Studies and Vendors” »

Integrating Transition/Exit Plans & Knowledge Transfer With QMS, Risk Registers and Governance Committees Integrating Transition/Exit Plans & Knowledge Transfer With QMS, Risk Registers and Governance Committees The clinical trial environment is characterized by a dynamic landscape where various stakeholders—including sponsor organizations, contract research organizations (CROs), and clinical research labs—must effectively manage transitions and exits to…

Read More “Integrating Transition/Exit Plans & Knowledge Transfer With QMS, Risk Registers and Governance Committees” »

Future-Proofing Transition/Exit Plans & Knowledge Transfer for AI, Real-World Data and Platform Trials In the evolving landscape of clinical trials, particularly those conducting nida clinical trials, organizations must establish robust transition and exit plans to navigate the complexities of vendor oversight and outsourcing. This guide offers a comprehensive approach for clinical operations, regulatory affairs, and…

Read More “Future-Proofing Transition/Exit Plans & Knowledge Transfer for AI, Real-World Data and Platform Trials” »

Aligning Transition/Exit Plans & Knowledge Transfer With ICH E6(R3), GCP and Quality-by-Design Principles Aligning Transition/Exit Plans & Knowledge Transfer With ICH E6(R3), GCP and Quality-by-Design Principles In the clinical trial landscape, the evolution of methodologies and regulations has underscored the necessity to properly manage transition and exit plans along with knowledge transfer protocols. This article…

Read More “Aligning Transition/Exit Plans & Knowledge Transfer With ICH E6(R3), GCP and Quality-by-Design Principles” »

Transition and Exit Plans for Clinical Operations and Vendor Governance Teams In the dynamic field of clinical research, the need for efficient transition and exit strategies in clinical trials is imperative for maintaining compliance and operational continuity. This article provides a detailed step-by-step guide aimed at clinical operations, regulatory affairs, and medical affairs professionals in…

Read More “Transition/Exit Plans & Knowledge Transfer Checklists for Clinical Operations and Vendor Governance Teams” »

Common Pitfalls in Transition/Exit Plans & Knowledge Transfer—and How to Avoid Regulatory Findings Common Pitfalls in Transition/Exit Plans & Knowledge Transfer—and How to Avoid Regulatory Findings The complexity of clinical trials necessitates robust planning at every stage, particularly during transitions and exits. These critical phases not only involve logistical considerations but also the safeguarding of…

Read More “Common Pitfalls in Transition/Exit Plans & Knowledge Transfer—and How to Avoid Regulatory Findings” »

Using KPIs and SLAs to Optimize Transition/Exit Plans & Knowledge Transfer Across CROs and Service Providers Using KPIs and SLAs to Optimize Transition/Exit Plans & Knowledge Transfer Across CROs and Service Providers The landscape of clinical trials is evolving, with a notable demand for effective vendor oversight and outsourcing strategies. This complexity increases with the…

Read More “Using KPIs and SLAs to Optimize Transition/Exit Plans & Knowledge Transfer Across CROs and Service Providers” »